摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-O-acetyl-1,6:3,4-dianhydro-β-D-talopyranose | 71856-31-0

中文名称
——
中文别名
——
英文名称
2-O-acetyl-1,6:3,4-dianhydro-β-D-talopyranose
英文别名
1,6:3,4-Dianhydro-2-O-acetyl-beta-d-talopyranose;[(1R,2S,4S,5S,6R)-3,7,9-trioxatricyclo[4.2.1.02,4]nonan-5-yl] acetate
2-O-acetyl-1,6:3,4-dianhydro-β-D-talopyranose化学式
CAS
71856-31-0
化学式
C8H10O5
mdl
——
分子量
186.164
InChiKey
JVBICOCAMPYKMA-IMFYSGRJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.6
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    57.3
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-O-acetyl-1,6:3,4-dianhydro-β-D-talopyranose 在 sodium azide 、 Dowex resin (50W-X8 acidic) 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 20.0h, 生成
    参考文献:
    名称:
    Synthesis of Methylene-Expanded 2‘,3‘-Dideoxyribonucleosides
    摘要:
    A method for the preparation of methylene-expanded 2',3'-dideoxyribonucleosides is reported. The very inexpensive starting material levoglucosenone 8 was converted into the known mixture of alcohols 12ab which were converted into the required silyl ether alcohol 26 in six steps via either of two routes. The first involved a one-step acetylation and opening of the anhydro sugar bridge to give the triacetates 20ab which were reduced with triethylsilane and silyl triflate to afford the diacetates 21ab, both of which gave 26 after further functional group conversions. The second route entailed a simple acetylation of 12ab followed by reduction with triethylsilane and silyl triflate to give the monoacetates 19ab, both converted via straightforward chemistry into 26. Mesylation of the alcohol of 26 furnished the mesylate 27. Alkylation of adenine with the mesylate 27 afforded the silyl ether 28 which was deprotected to give the desired modified dideoxy nucleoside 7a. Alkylation of 2,6-diaminopurine 38 with the mesylate gave the protected diaminopurine nucleoside 39. Upon acetylation, it produced a mixture of di- and monoacetates 40-41, the latter of which was transformed into the desired guanosine analogue 7e. Thus, two new nucleoside analogues 7ae were prepared from levoglucosenone 8.
    DOI:
    10.1021/jo980436l
  • 作为产物:
    参考文献:
    名称:
    Synthesis of Methylene-Expanded 2‘,3‘-Dideoxyribonucleosides
    摘要:
    A method for the preparation of methylene-expanded 2',3'-dideoxyribonucleosides is reported. The very inexpensive starting material levoglucosenone 8 was converted into the known mixture of alcohols 12ab which were converted into the required silyl ether alcohol 26 in six steps via either of two routes. The first involved a one-step acetylation and opening of the anhydro sugar bridge to give the triacetates 20ab which were reduced with triethylsilane and silyl triflate to afford the diacetates 21ab, both of which gave 26 after further functional group conversions. The second route entailed a simple acetylation of 12ab followed by reduction with triethylsilane and silyl triflate to give the monoacetates 19ab, both converted via straightforward chemistry into 26. Mesylation of the alcohol of 26 furnished the mesylate 27. Alkylation of adenine with the mesylate 27 afforded the silyl ether 28 which was deprotected to give the desired modified dideoxy nucleoside 7a. Alkylation of 2,6-diaminopurine 38 with the mesylate gave the protected diaminopurine nucleoside 39. Upon acetylation, it produced a mixture of di- and monoacetates 40-41, the latter of which was transformed into the desired guanosine analogue 7e. Thus, two new nucleoside analogues 7ae were prepared from levoglucosenone 8.
    DOI:
    10.1021/jo980436l
点击查看最新优质反应信息

文献信息

  • Synthesis of Methylene-Expanded 2‘,3‘-Dideoxyribonucleosides
    作者:Michael E. Jung、Mehrak Kiankarimi
    DOI:10.1021/jo980436l
    日期:1998.11.1
    A method for the preparation of methylene-expanded 2',3'-dideoxyribonucleosides is reported. The very inexpensive starting material levoglucosenone 8 was converted into the known mixture of alcohols 12ab which were converted into the required silyl ether alcohol 26 in six steps via either of two routes. The first involved a one-step acetylation and opening of the anhydro sugar bridge to give the triacetates 20ab which were reduced with triethylsilane and silyl triflate to afford the diacetates 21ab, both of which gave 26 after further functional group conversions. The second route entailed a simple acetylation of 12ab followed by reduction with triethylsilane and silyl triflate to give the monoacetates 19ab, both converted via straightforward chemistry into 26. Mesylation of the alcohol of 26 furnished the mesylate 27. Alkylation of adenine with the mesylate 27 afforded the silyl ether 28 which was deprotected to give the desired modified dideoxy nucleoside 7a. Alkylation of 2,6-diaminopurine 38 with the mesylate gave the protected diaminopurine nucleoside 39. Upon acetylation, it produced a mixture of di- and monoacetates 40-41, the latter of which was transformed into the desired guanosine analogue 7e. Thus, two new nucleoside analogues 7ae were prepared from levoglucosenone 8.
查看更多

同类化合物

绿木霉菌素 甲基2,3-脱水-4,6-O-亚苄基-Alpha-D-吡喃糖苷 甲基 2,3-脱水-4,6-亚苄基-ALPHA-D-吡喃甘露糖苷 替达霉素B 替达霉素A 普罗孕酮 戊二酰-2-(羟甲基)蒽并醌 反式-4-环己烯-1,2-二羰基二氯 二氧杂环庚烷 乙基(1R,7S,8r)-3,5-二氧杂双环[5.1.0]辛烷-8-羧酸酯 三乙基二胺 alpha-高-3-脱氧-3,3-二甲基-2,4-二氧杂-25-羟基维他命D3 8,8-二氯-4-乙基-3,5-二氧杂双环[5.1.0]辛烷 7,12-二氧杂螺[5.6]十二烷-10-基甲醇 7,12-二氧杂螺(5.6)十二烷 7,12-二氧杂螺(5,6)十二烷-3-酮 6-[(1E,3E,5E)-6-[(1S,2S,3R,5R,6R)-2,8-二羟基-1,3,5,6-四甲基-4,7-二氧杂双环[3.2.1]辛烷-3-基]己-1,3,5-三烯基]-4-甲氧基-5-甲基吡喃-2-酮 5-甲氧基-7,12-二氧杂螺[5.6]十二烷 5-溴-7,12-二氧杂螺[5.6]十二烷 5-氟-5,7,7-三(三氟甲基)-6-[2,2,2-三氟-1-(三氟甲基)乙亚基]-1,4-二氧杂环庚烷 5,5,6,6-四氟-1,3-二氧杂环庚烷 4-苯基-3,5,8-三氧杂双环[5.1.0]辛烷 4,5-环氧-2-甲氧基-6-甲基-四氢-吡喃-3-醇 4,4-二甲基-3,5,8-三氧杂双环[5,1,0]辛烷 4,4-[(3,20-二氧代孕甾-4-烯-14,17-二基)二氧基]丁酸 3’,5’-脱水胸苷 3-(2-甲基-2-丙基)-7,12-二氧杂螺[5.6]十二烷 3,7,9-三氧杂三环[4.2.1.02,4]壬烷-5-醇 3,7,10-三氧杂三环[4.3.1.02,4]癸烷 3,6-二氧杂-1-环庚醇 3,4-环氧-4-甲基四氢吡喃 2-亚甲基-1,3-二氧烷 2,5-邻亚甲基-d-甘露醇 1-羟基-3,6-二氧杂双环[3.2.1]辛烷-2-酮 1-甲基-4,7-二氧杂双环[4.1.0]庚烷 1-[3-(1,3-二氧杂环庚烷)苯基]-环丙胺 1-(3,5-脱水-2-脱氧-Β-D-苏-戊呋喃糖基)胸腺嘧啶 1,6:2,3-二酐-β-D-吡喃甘露糖 1,5:3,4-二去氢-2-脱氧戊糖醇 1,5:2,3-二脱水-4,6-O-亚苄基-D-蒜糖醇 1,5:2,3-二脱水-4,6-O-[(R)-苯基亚甲基]-D-蒜糖醇 1,5-二氧杂环庚烷-2-酮 1,4-二氧杂环庚烷-6-酮 1,3:2,5:4,6-三-o-亚甲基-D-甘露糖醇 1,3-二氧杂草 1,3-二噁庚环-5-醇,2,2-二甲基-6-(1,4,7,10-四氮杂环十二碳-1-基)- 1,2:3,4-二环氧环戊烷 (5R)-2,2-二甲基-1,3-二氧杂环庚烷-5-甲醛 (1R,2R)-2-[(1aS,8aS)-4beta-(3-呋喃基)-八氢-4abeta-甲基-8-亚甲基-2-氧代环氧乙烷并[d][2]苯并吡喃-7alpha-基]-2,6,6-三甲基-5-氧代-3-环己烯-1-乙酸甲酯 (1S,2S,4S,5S)-1-azido-2-hydroxymethyl-4-(thymin-1-yl)-3,6-dioxabicyclo[3.2.0]heptane